Conroy Sun

My group is focused on applying nanotechnology toward unanswered problems in cancer care. In particular, we are interested in developing novel nanomaterials that serve as platforms for tumor targeted drug delivery and molecular imaging contrast agents. Here we seek to exploit the multifunctional capabilities of nanomaterials to combine conventional therapies, such as radiation and chemotherapy, to achieve a synergistic treatment response or combine treatment with medical imaging modalities for theranostic approaches, such as image-guided drug delivery. In addition, a significant portion of my research is directed toward enabling novel treatment or imaging technologies that are only possible through the use of nanotechnology. For example, in collaboration with colleagues at the Molecular Imaging Program at Stanford (MIPS), we have developed tumor targeted radioluminescent nanoparticles (RLNP) that serve as a centerpiece for a new in vivo imaging platform, X-ray luminescence computed tomography (XLCT). As a potential drug delivery platform, we are currently investigating the ability of RLNPs to serve as stimuli-responsive carriers for controlled release or energy mediators for deep tissue photodynamic therapy.
TECHNOLOGIES
Inverse Micelle Preparation for Alginate-Based Drug Delivery Carriers
SECTORS
Earth Ecosystems
Health and Wellness
Innovation and Prosperity
CATEGORIES
Agricultural
Biological Materials
Chemical
Chemistry
Communications
Computer
Database
Device
Diagnostics
Digital
Education & Training
Electronics
Engineering
FakeName
Imaging
Information Technology
Materials Science
Medical
Medical Devices
Nanoscience & Microtechnologies
Physical Science
Research Tools
Software
Sustainability & Cleantechnologies
Therapeutics
Transportation
Vaccines
© 2019. All Rights Reserved. Powered by Inteum